such as late-onset congenital adrenal hyperplasia and Cushing's syndrome. The more recent 2003 Rotterdam consensus workshop was in response to an increasing awareness that the clinical expression ...
Analysts at Zacks Research increased their Q1 2025 EPS estimates for shares of Corcept Therapeutics in a report released on Wednesday, January 29th. Zacks Research analyst K. Das now expects that the ...
David James, director of patient projects and influencing at Prostate Cancer Research, has set the record straight on some of ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback